PPA
GMAB icon

Parametric Portfolio Associates’s Genmab GMAB Stock Holding History

Parametric Portfolio Associates’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$29.8M Buy
823,618
+88,263
+12% +$3.03M 0.02% 767
2021
Q4 		$29.1M Sell
735,355
-31,228
-4% -$1.3M 0.01% 764
2021
Q3 		$33.5M Buy
766,583
+44,692
+6% +$2.01M 0.02% 699
2021
Q2 		$29.5M Buy
721,891
+65,012
+10% +$2.51M 0.02% 764
2021
Q1 		$21.6M Buy
656,879
+89,208
+16% +$3.35M 0.01% 1106
2020
Q4 		$23.1M Buy
567,671
+19,973
+4% +$747K 0.01% 949
2020
Q3 		$20.1M Buy
547,698
+34,014
+7% +$1.23M 0.01% 892
2020
Q2 		$17.4M Buy
513,684
+33,612
+7% +$916K 0.01% 963
2020
Q1 		$10.2M Buy
480,072
+2,843
+0.6% +$63.4K 0.01% 1226
2019
Q4 		$10.7M Buy
477,229
+52,756
+12% +$1.15M 0.01% 1469
2019
Q3 		$8.6M Buy
+424,473
New +$8.36M 0.01% 1577

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

Parametric Portfolio Associates's GMAB Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Genmab (GMAB) stake by 12% in Q1 2022, buying an estimated $3.03M and bringing the position to 823,618 shares worth $29.8M. The position accounts for 0.02% of the portfolio, ranked #767.

Parametric Portfolio Associates first reported a position in GMAB in Q3 2019 and has held it in 11 quarters since. The position peaked at $33.5M in Q3 2021. 205 funds tracked by Wall St. Rank hold GMAB as of Q1 2022.

  • Parametric Portfolio Associates held 823,618 shares of Genmab worth $29.8M as of Q1 2022.
  • Parametric Portfolio Associates bought 88,263 Genmab shares in Q1 2022, an estimated $3.03M.
  • Genmab made up 0.02% of Parametric Portfolio Associates's portfolio in Q1 2022, its #767 holding.
  • Parametric Portfolio Associates first reported a position in Genmab in Q3 2019 and has held it in 11 quarters since.
  • Parametric Portfolio Associates's Genmab position peaked at $33.5M in Q3 2021.
  • 205 funds tracked by Wall St. Rank held Genmab as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.